Myelodysplastic syndromes (MDS) and AML are hematological malignancies associated with aberrant splicing patterns [10] and FLT3 is one of the most mis-spliced genes in AML, dysregulation of the splicing process can also disturb apoptosis and cause resistance to therapies [4]. This evidence concerns the gene FLT3 and acute myeloid leukemia.